-
-
-
-
-
-
-
Mainz Biomed (MYNZ) Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study
-
-
-
-
-
-
-
Mainz Biomed (MYNZ) Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
-
-
-
-
-
-
-
Mainz Biomed (MYNZ) Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

